Explore / Clinical trial
Clinical trial

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Minneapolis Veterans Affairs Medical CenterCompletedPhase 1Started May 1, 201520 enrolledUnited StatesNCT02577250

Abstract

The relationship between depression and trauma is well established. Co-occuring depression and post-traumatic stress disorder (PTSD) are associated with more severe symptoms and lower levels of functioning. Veterans with both depression and PTSD have been shown to be at much higher risk of suicide than individuals with only one of these disorders. Ketamine has been shown to have rapid antidepressant effects and also therapeutic action over PTSD symptoms. The purpose of this study is to see whether ketamine, when given as repeated infusions, can produce quick and sustained improvement in depression and PTSD symptoms for individuals who have not had their symptoms effectively treated by current treatments.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepressionPTSD

Keywords

stress disorders, post-traumaticstress disorders, traumaticanxiety disordersmental disordersadjuvants, anesthesiaanalgesicsanestheticsanesthetics, dissociativeanesthetics, generalanesthetics, intravenousexcitatory amino acid agentsexcitatory amino acid antagonistshypnotics and sedativesmolecular mechanisms of pharmacological actionneurotransmitter agents

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.